- Home
- /
- Drugs
- /
- I
- /
- Itraconazole
- /
- Itraconazole ITRACONAZOLE 100 mg/1 Zydus Lifesciences Limited
Itraconazole
- Itraconazole ITRACONAZOLE 100 mg/1 Zydus Pharmaceuticals USA Inc.
- ITRACONAZOLE ITRACONAZOLE 100 mg/1 Alembic Pharmaceuticals Inc.
- SPORANOX ITRACONAZOLE 100 mg/1 Janssen Pharmaceuticals, Inc.
- ITRACONAZOLE ITRACONAZOLE 100 mg/1 REMEDYREPACK INC.
- SPORANOX ITRACONAZOLE 100 mg/1 Janssen Pharmaceuticals, Inc.
- Itraconazole ITRACONAZOLE 100 mg/1 Patriot Pharmaceuticals
- Itraconazole ITRACONAZOLE 100 mg/1 Amneal Pharmaceuticals LLC
- ITRACONAZOLE ITRACONAZOLE 100 mg/1 Alembic Pharmaceuticals Limited
- Itraconazole ITRACONAZOLE 100 mg/1 Par Pharmaceutical, Inc.
- Itraconazole ITRACONAZOLE 100 mg/1 American Health Packaging
- Itraconazole ITRACONAZOLE 100 mg/1 Torrent Pharmaceuticals Limited
- Itraconazole ITRACONAZOLE 100 mg/1 Accord Healthcare Inc.
- Itraconazole ITRACONAZOLE 100 mg/1 Zydus Lifesciences Limited
- Itraconazole ITRACONAZOLE 100 mg/1 Torrent Pharmaceuticals Limited
Summary of product characteristics
Effective Time
20221013
Version
5
Spl Product Data Elements
itraconazole itraconazole ITRACONAZOLE ITRACONAZOLE FD&C BLUE NO. 1 FD&C RED NO. 3 GELATIN HYPROMELLOSE 2910 (5 MPA.S) SODIUM LAURYL SULFATE POLYETHYLENE GLYCOL, UNSPECIFIED SUCROSE TALC TITANIUM DIOXIDE BUTYL ALCOHOL ALCOHOL ISOPROPYL ALCOHOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL WATER SHELLAC AMMONIA POLOXAMER 188 BLUE CAPSULE ZA;65;100;mg
Application Number
ANDA204672
Brand Name
Itraconazole
Generic Name
itraconazole
Product Ndc
70771-1208
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Itraconazole Capsules, 100 mg NDC 70771-1208-3 30 Capsules Itraconazole Capsules
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.